BMS-986453
Study of BMS-986453 in Newly Diagnosed Multiple Myeloma
What will happen during the trial?
This is an open-label study. The investigators propose to examine if BMS-986453 in people with newly diagnosed multiple myeloma may help control their disease for a prolonged period of time despite one-time treatment and challenge continuous treatment which is otherwise prescribed.
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 1
- Enrollment
- 25 patients (estimated)
- Tags
- CAR T Cell, B-Cell Maturation Antigen (BCMA), GPRC5D
- Trial Type
- Treatment
- Last Update
- SparkCures ID
- 2209
- NCT Identifier
- NCT07333261
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.